Yue-zu Fan

389 Xincun Road
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Correction to: Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.

Correction to: Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 18, 2021

Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer-associated fibroblasts.

Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer-associated fibroblasts.

Journal: Cancer medicine

Published: February 16, 2021

Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.

Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 22, 2020

Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities.

Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities.

Journal: Chinese medicine

Published: March 29, 2020

Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.

Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.

Journal: Cancer chemotherapy and pharmacology

Published: March 07, 2020

Upregulated NOX1 expression in gallbladder cancer‑associated fibroblasts predicts a poor prognosis.

Upregulated NOX1 expression in gallbladder cancer‑associated fibroblasts predicts a poor prognosis.

Journal: Oncology reports

Published: December 11, 2018

Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer.

Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer.

Journal: Oncology letters

Published: June 12, 2018

Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.

Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.

Journal: Cancer cell international

Published: December 18, 2016

Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.

Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.

Journal: Oncotarget

Published: December 10, 2016

A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.

A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.

Journal: BMC cancer

Published: April 06, 2015

Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.

Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.

Journal: International journal of oncology

Published: September 12, 2014

Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.

Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.

Journal: PloS one

Published: November 18, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026